Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 22-Week Randomized, Cross-Over Study Comparing the Effects of Quinapril and Quinapril Plus Alpha-Lipoic Acid (ALA) on Patients With Diabetes Mellitus and Hypertension.

Next Previous
Trial Profile

A 22-Week Randomized, Cross-Over Study Comparing the Effects of Quinapril and Quinapril Plus Alpha-Lipoic Acid (ALA) on Patients With Diabetes Mellitus and Hypertension.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Quinapril; Thioctic acid
  • Indications Diabetic nephropathies; Hypertension; Metabolic syndrome; Proteinuria
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms QUALITY

Most Recent Events

  • 05 May 2011 Biomarkers information updated
  • 14 Mar 2010 Secondary endpoint results presented at the 59th Annual Scientific Session of the American College of Cardiology (ACC 2010).
  • 09 Oct 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top